PortfoliosLab logo
BSX vs. BDX
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between BSX and BDX is 0.46, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Performance

BSX vs. BDX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Boston Scientific Corporation (BSX) and Becton, Dickinson and Company (BDX). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

BSX:

1.85

BDX:

-0.93

Sortino Ratio

BSX:

2.46

BDX:

-1.06

Omega Ratio

BSX:

1.40

BDX:

0.82

Calmar Ratio

BSX:

2.84

BDX:

-0.65

Martin Ratio

BSX:

11.56

BDX:

-2.72

Ulcer Index

BSX:

3.81%

BDX:

9.57%

Daily Std Dev

BSX:

22.26%

BDX:

28.20%

Max Drawdown

BSX:

-89.15%

BDX:

-51.17%

Current Drawdown

BSX:

-1.24%

BDX:

-37.47%

Fundamentals

Market Cap

BSX:

$152.31B

BDX:

$49.02B

EPS

BSX:

$1.37

BDX:

$5.15

PE Ratio

BSX:

75.15

BDX:

33.21

PEG Ratio

BSX:

2.54

BDX:

0.80

PS Ratio

BSX:

8.68

BDX:

2.35

PB Ratio

BSX:

6.86

BDX:

1.99

Total Revenue (TTM)

BSX:

$17.55B

BDX:

$20.87B

Gross Profit (TTM)

BSX:

$11.79B

BDX:

$9.29B

EBITDA (TTM)

BSX:

$4.09B

BDX:

$3.52B

Returns By Period

In the year-to-date period, BSX achieves a 17.40% return, which is significantly higher than BDX's -23.72% return. Over the past 10 years, BSX has outperformed BDX with an annualized return of 19.28%, while BDX has yielded a comparatively lower 3.75% annualized return.


BSX

YTD

17.40%

1M

11.28%

6M

19.72%

1Y

40.85%

5Y*

24.75%

10Y*

19.28%

BDX

YTD

-23.72%

1M

-14.73%

6M

-23.46%

1Y

-26.13%

5Y*

-5.96%

10Y*

3.75%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

BSX vs. BDX — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BSX
The Risk-Adjusted Performance Rank of BSX is 9494
Overall Rank
The Sharpe Ratio Rank of BSX is 9595
Sharpe Ratio Rank
The Sortino Ratio Rank of BSX is 9191
Sortino Ratio Rank
The Omega Ratio Rank of BSX is 9494
Omega Ratio Rank
The Calmar Ratio Rank of BSX is 9696
Calmar Ratio Rank
The Martin Ratio Rank of BSX is 9696
Martin Ratio Rank

BDX
The Risk-Adjusted Performance Rank of BDX is 77
Overall Rank
The Sharpe Ratio Rank of BDX is 66
Sharpe Ratio Rank
The Sortino Ratio Rank of BDX is 1111
Sortino Ratio Rank
The Omega Ratio Rank of BDX is 77
Omega Ratio Rank
The Calmar Ratio Rank of BDX is 1111
Calmar Ratio Rank
The Martin Ratio Rank of BDX is 00
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

BSX vs. BDX - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Boston Scientific Corporation (BSX) and Becton, Dickinson and Company (BDX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current BSX Sharpe Ratio is 1.85, which is higher than the BDX Sharpe Ratio of -0.93. The chart below compares the historical Sharpe Ratios of BSX and BDX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Dividends

BSX vs. BDX - Dividend Comparison

BSX has not paid dividends to shareholders, while BDX's dividend yield for the trailing twelve months is around 2.31%.


TTM20242023202220212020201920182017201620152014
BSX
Boston Scientific Corporation
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
BDX
Becton, Dickinson and Company
2.31%1.71%1.51%1.38%1.34%1.28%1.14%1.34%1.37%1.64%1.60%1.61%

Drawdowns

BSX vs. BDX - Drawdown Comparison

The maximum BSX drawdown since its inception was -89.15%, which is greater than BDX's maximum drawdown of -51.17%. Use the drawdown chart below to compare losses from any high point for BSX and BDX. For additional features, visit the drawdowns tool.


Loading data...

Volatility

BSX vs. BDX - Volatility Comparison

The current volatility for Boston Scientific Corporation (BSX) is 5.80%, while Becton, Dickinson and Company (BDX) has a volatility of 21.26%. This indicates that BSX experiences smaller price fluctuations and is considered to be less risky than BDX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

BSX vs. BDX - Financials Comparison

This section allows you to compare key financial metrics between Boston Scientific Corporation and Becton, Dickinson and Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


2.00B2.50B3.00B3.50B4.00B4.50B5.00B5.50B20212022202320242025
4.66B
5.27B
(BSX) Total Revenue
(BDX) Total Revenue
Values in USD except per share items

BSX vs. BDX - Profitability Comparison

The chart below illustrates the profitability comparison between Boston Scientific Corporation and Becton, Dickinson and Company over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

30.0%40.0%50.0%60.0%70.0%20212022202320242025
68.8%
42.8%
(BSX) Gross Margin
(BDX) Gross Margin
BSX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Boston Scientific Corporation reported a gross profit of 3.21B and revenue of 4.66B. Therefore, the gross margin over that period was 68.8%.

BDX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Becton, Dickinson and Company reported a gross profit of 2.26B and revenue of 5.27B. Therefore, the gross margin over that period was 42.8%.

BSX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Boston Scientific Corporation reported an operating income of 921.00M and revenue of 4.66B, resulting in an operating margin of 19.8%.

BDX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Becton, Dickinson and Company reported an operating income of 546.00M and revenue of 5.27B, resulting in an operating margin of 10.4%.

BSX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Boston Scientific Corporation reported a net income of 674.00M and revenue of 4.66B, resulting in a net margin of 14.5%.

BDX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Becton, Dickinson and Company reported a net income of 308.00M and revenue of 5.27B, resulting in a net margin of 5.8%.